The global insulin in dosage market is led by China, boasting the highest value share. Notable growth over the past year includes China's 3.16% increase and Belgium's 3.78% rise. Conversely, Japan experienced a significant decline of 8.01%. A consistent trend over five years emerges with China's growing dominance, supported by a promising CAGR. Countries such as Greece have shown resilience by posting positive year-on-year growth.
Looking ahead, the focus is expected to be on emerging markets and innovations in insulin delivery methods. The expanding diabetic population in developing economies presents lucrative opportunities, demanding strategic responses from major players. Additionally, collaborative efforts in research and development are vital for future market shares.
Top countries in Insulin in Dosage Market Size Value Share by Country (US Dollars)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 29.75 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 14.41 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 10.78 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 7.92 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 7.76 | 2023 | -14.34% | -8.01% | View data |
| 6 | 6 Italy | 6.65 | 2023 | -2.49% | -2.35% | View data |
| 7 | 7 Spain | 4.69 | 2023 | -1.52% | -0.44% | View data |
| 8 | 8 Australia | 3.24 | 2023 | -0.72% | -0.31% | View data |
| 9 | 9 Netherlands | 2.5 | 2023 | +3.4% | -0.08% | View data |
| 10 | 10 Czech Republic | 1.92 | 2023 | +1.22% | +0.83% | View data |
